about
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loadingMitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses.Cancer immunotherapy: the past, the present and the future.Targeted immunotherapy of cancer: development of antibody-induced cellular immunity.Dendritic cell-based immunotherapy for the treatment of hematological malignancies.Novel therapeutic agents under investigation for malignant melanoma.Dendritic cell vaccination and immunostimulation in advanced melanoma.Vaccination as a treatment for breast or ovarian cancer.Dendritic cell-based immunotherapy of malignant gliomas.Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells.Noncoding RNAs in Cancer Immunology.Antitumor effect of dendritic cell loaded ex vivo and in vivo with tumor-associated antigens in lung cancer model.RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer.Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo.Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes.Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells.Lycium barbarum Polysaccharide Promotes Maturation of Dendritic Cell via Notch Signaling and Strengthens Dendritic Cell Mediated T Lymphocyte Cytotoxicity on Colon Cancer Cell CT26-WT.
P2860
Q24815134-CA19F1A4-C967-4640-8234-9A7332396C64Q26748776-E075A0E5-CAE5-4CF2-9044-3E0C432B3630Q33595455-6B5E452E-531D-4C41-A512-3E117EE103D8Q33786246-2205192E-5E28-4D22-90DA-0219D455C38EQ35083647-0C26FD9F-7A42-434F-84B6-8CDF3B6CF7E0Q35084986-11A0C391-F357-4634-9EF9-948FB345664DQ35127001-35E51D5B-7658-4532-8097-2724A9E27245Q35207632-7278AD79-E862-4395-8F35-3A60AC095742Q35623395-1DCD9A68-D0D3-441F-8252-FA5FA1F61CDCQ35791759-AC38D358-4E74-418C-9428-4B7AD577E828Q35922426-C87F62FB-EF50-45CA-BFA3-DF4CC18F8CC9Q36164524-EFC4B68F-E7E2-444D-8F43-F7A26DF404ABQ36194575-856B87D4-17D0-4949-A92D-4A0988381C55Q38885490-4E03D8B3-D694-4560-8F70-2755A96BA590Q39013263-07541892-6015-4350-A32F-5983627F7116Q40002875-2FD96873-4E80-4A66-B1D3-2C48E74B364AQ40663872-663B9FA1-805B-47B5-87EF-470F9C92C190Q40664478-F55AAF5C-1578-4619-A4A8-E0655168B4DBQ40668644-26463A4D-033E-48FF-B73C-3C5F689C6D6BQ45881751-80C4C203-B0B9-401A-9C32-4DEBBA4600F2Q51064979-B63FF4FA-A0FE-44BB-AEBE-18A87AF622CAQ52606111-10EF3878-AAF3-4AD7-8CDB-5FA5AFB810C4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dendritic cells in cancer vaccines.
@ast
Dendritic cells in cancer vaccines.
@en
Dendritic cells in cancer vaccines.
@nl
type
label
Dendritic cells in cancer vaccines.
@ast
Dendritic cells in cancer vaccines.
@en
Dendritic cells in cancer vaccines.
@nl
prefLabel
Dendritic cells in cancer vaccines.
@ast
Dendritic cells in cancer vaccines.
@en
Dendritic cells in cancer vaccines.
@nl
P2093
P1476
Dendritic cells in cancer vaccines.
@en
P2093
P304
P356
10.1016/S0301-472X(01)00730-5
P577
2001-11-01T00:00:00Z